Pharmacoeconomic Evaluation of Anerning Granules in the Treatment of Upper Respiratory Tract Infection in Children
Objective To evaluate the economy of Anerning granule in treating upper respiratory tract infection in children.Methods Based on the perspective of health system,the cost-effectiveness analysis method was used to compare the cost-effectiveness of An'erning granules in the treatment of upper respiratory tract infection in children compared with Xiaoer's cold granules,and the sensitivity analysis was carried out.Results Compared with children's common flu granules,the cost of An'erning granules increased by 0.55 yuan for each 1%increase in efficacy,which was significantly lower than the willing payment threshold(85.7 yuan),indicating that An'erning granules had cost-outcome advantages.In the case of better effect,the expected cost difference between An'erning granule treatment scheme and children's cold granule treatment scheme is smaller and more economical.The results of sensitivity analysis show that the cost-effectiveness analysis is robust.Conclusion In the treatment of upper respiratory tract infection in children,the cost-effect advantages over cold particles in children are obvious.
国家科技期刊平台
NSTL
万方数据
